DexCom Inc. [NASDAQ: DXCM] slipped around -22.46 points on Thursday, while shares priced at $362.71 at the close of the session, down -5.83%. DexCom Inc. stock is now 65.82% up from its year-to-date (YTD) trading value. DXCM Stock saw the intraday high of $381.57 and lowest of $360.918 per share. The company’s 52-week high price is 428.59, which means current price is +99.21% above from all time high which was touched on 05/18/20.
Compared to the average trading volume of 1.92M shares, DXCM reached a trading volume of 1286824 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
What do top market gurus say about DexCom Inc. [DXCM]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for DXCM shares is $382.38 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on DXCM stock is a recommendation set at 1.60. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Piper Sandler have made an estimate for DexCom Inc. shares, keeping their opinion on the stock as Overweight, with their previous recommendation back on May 27, 2020. While these analysts kept the previous recommendation, Wells Fargo raised their target price to Equal Weight. The new note on the price target was released on May 14, 2020, representing the official price target for DexCom Inc. stock. Previously, the target price had yet another raise to $330, while Citigroup analysts kept a Buy rating on DXCM stock.
The Average True Range (ATR) for DexCom Inc. is set at 20.42, with the Price to Sales ratio for DXCM stock in the period of the last 12 months amounting to 20.22. The Price to Book ratio for the last quarter was 35.63, with the Price to Cash per share for the same quarter was set at 16.93. Price to Free Cash Flow for DXCM in the course of the last twelve months was 247.60 with Quick ratio for the last quarter at 5.40.
How has DXCM stock performed recently?
DexCom Inc. [DXCM] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 5.18. With this latest performance, DXCM shares dropped by -11.71% in over the last four-week period, additionally plugging by 68.29% over the last 6 months – not to mention a rise of 149.68% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for DXCM stock in for the last two-week period is set at 48.58, with the RSI for the last a single of trading hit 43.95, and the three-weeks RSI is set at 50.85 for DexCom Inc. [DXCM]. The present Moving Average for the last 50 days of trading for this stock 347.46, while it was recorded at 372.30 for the last single week of trading, and 243.60 for the last 200 days.
DexCom Inc. [DXCM]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and DexCom Inc. [DXCM] shares currently have an operating margin of +9.64 and a Gross Margin at +63.11. DexCom Inc.’s Net Margin is presently recorded at +6.85.
Return on Total Capital for DXCM is now 7.64, given the latest momentum, and Return on Invested Capital for the company is 5.45. Return on Equity for this stock inclined to 13.08, with Return on Assets sitting at 4.69. When it comes to the capital structure of this company, DexCom Inc. [DXCM] has a Total Debt to Total Equity ratio set at 131.44. Additionally, DXCM Total Debt to Total Capital is recorded at 56.79, with Total Debt to Total Assets ending up at 48.44. Long-Term Debt to Equity for the company is recorded at 129.90, with the Long-Term Debt to Total Capital now at 56.13.
Reflecting on the efficiency of the workforce at the company, DexCom Inc. [DXCM] managed to generate an average of $19,442 per employee. Receivables Turnover for the company is 5.75 with a Total Asset Turnover recorded at a value of 0.68.DexCom Inc.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 5.40 and a Current Ratio set at 5.80.
Earnings analysis for DexCom Inc. [DXCM]
With the latest financial reports released by the company, DexCom Inc. posted 0.08/share EPS, while the average EPS was predicted by analysts to be reported at 0.01/share.When compared, the two values demonstrate that the company surpassed the estimates by a Surprise Factor of 700.00%. The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for DXCM. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for DexCom Inc. go to 51.95%.
Insider trade positions for DexCom Inc. [DXCM]
There are presently around $35,146 million, or 98.00% of DXCM stock, in the hands of institutional investors. The top three institutional holders of DXCM stocks are: FMR LLC with ownership of 8,780,437, which is approximately 25.152% of the company’s market cap and around 0.80% of the total institutional ownership; VANGUARD GROUP INC, holding 8,743,713 shares of the stock with an approximate value of $3.37 billion in DXCM stocks shares; and BLACKROCK INC., currently with $2.29 billion in DXCM stock with ownership of nearly 8.248% of the company’s market capitalization.
Positions in DexCom Inc. stocks held by institutional investors increased at the end of April and at the time of the April reporting period, where 342 institutional holders increased their position in DexCom Inc. [NASDAQ:DXCM] by around 9,724,137 shares. Additionally, 246 investors decreased positions by around 8,687,264 shares, while 57 investors held positions by with 72,835,793 shares. The mentioned changes placed institutional holdings at 91,247,194 shares, according to the latest SEC report filing. DXCM stock had 145 new institutional investments in for a total of 2,498,970 shares, while 54 institutional investors sold positions of 1,431,848 shares during the same period.